Decision Support Tool for HIV Treatment
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new software tool, smART (Smart Antiretroviral Therapy Assistant), designed to help doctors select the best HIV treatments for their patients. HIV treatment can be complex due to factors like drug resistance and other health issues. The study aims to determine if this tool enables doctors to make better treatment choices more quickly and confidently. Individuals who might benefit from this trial include those with HIV who have undergone resistance testing for medications. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could simplify and enhance HIV treatment decisions.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop your current medications. It focuses on using a decision support tool to help providers choose HIV treatments.
What prior data suggests that this decision support tool is safe for use in HIV treatment?
Research has shown that the smART (Smart Antiretroviral Therapy Assistant) tool assists doctors in selecting the best HIV treatments for their patients. This tool offers recommendations based on guidelines to simplify treatment decisions. It is important to note that smART is not a medication or treatment but a digital tool for decision-making.
As a software tool, smART poses no direct safety concerns for patients. It does not interact with the body like a drug. Instead, it aids doctors in choosing the right HIV treatments, potentially leading to better patient outcomes. The goal is to simplify the process for healthcare providers, particularly those without easy access to HIV specialists.12345Why are researchers excited about this trial?
Researchers are excited about the smART (Smart Antiretroviral Therapy Assistant) because it offers a new way to personalize HIV treatment. Unlike traditional online resources that provide general guidelines, smART is a digital tool that gives tailored, guideline-based recommendations specifically for each patient. This personalized approach could lead to more effective treatment plans and better patient outcomes. By integrating advanced decision-support technology, smART has the potential to streamline the decision-making process for healthcare providers, ultimately enhancing the quality of HIV care.
What evidence suggests that the smART tool is effective for HIV treatment?
Studies have shown that antiretroviral therapy (ART) helps people with HIV live longer and enjoy a better quality of life. It also reduces the risk of spreading HIV to others. This trial tests the smART tool, a digital clinical decision support tool, to assist doctors in selecting the best ART combinations for their patients. Although not yet fully tested in people, it aims to make treatment decisions quicker and more accurate by adhering to clinical guidelines. This tool could be particularly beneficial for doctors who do not specialize in HIV care, ensuring patients receive optimal treatment. Participants in this trial will use either the smART tool or traditional prescribing resources to guide their treatment decisions.16789
Who Is on the Research Team?
Hayoun Lee, PhD
Principal Investigator
Keck School of Medicine of USC
Are You a Good Fit for This Trial?
This trial is for healthcare providers who prescribe HIV treatments. It aims to assist those who may not have specialist support in choosing the most effective antiretroviral therapy (ART) combinations for their patients with HIV/AIDS.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Healthcare providers use patient cases to compare standard HIV treatment resources with a new clinical decision support tool
Follow-up
Participants are monitored for viral suppression rates and adherence to ART regimens
What Are the Treatments Tested in This Trial?
Interventions
- smART (Smart Antiretroviral Therapy Assistant)
Trial Overview
The study compares a new software tool, smART, designed to provide evidence-based ART recommendations at the point of care, against traditional prescribing resources used by healthcare providers.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
smART (Smart Antiretroviral Therapy Assistant): a digital clinical decision support tool that provides personalized, guideline-based HIV treatment recommendations.
standard online resources commonly accessed in HIV care, including the Stanford HIV Database, the IAS-USA Drug Resistance Mutations Chart, and the NIH HIV Clinical Guidelines.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Keck School of Medicine of USC
Lead Sponsor
Los Angeles General Medical Center
Collaborator
AIDS Healthcare Foundation
Collaborator
Citations
Evaluating a Clinical Decision Support Tool for ...
smART is a single-page, offline clinical decision support application that generates personalized HIV treatment recommendations by evaluating ...
Decision Support Tool for HIV Treatment · Info for Participants
This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients.
Major Clinical Outcomes in Antiretroviral Therapy (ART ...
Abstract. BackgroundThe SMART study randomized 5472 human immunodeficiency virus (HIV)–infected patients with CD4+ cell counts >350 cells/μL to intermit.
A Systematic Review of Antiretroviral Adherence Interventions ...
More conclusive data regarding the efficacy on cART adherence and HIV treatment outcomes using cognitive behavioral therapy, motivational interviewing, peer ...
Smartphone-based incentives for promoting adherence to ...
Antiretroviral therapy (ART) increases life expectancy and quality of life for individuals infected with HIV, and can reduce the chance of HIV transmission ( ...
Ingestible Electronic Sensors for Monitoring Real-time ...
Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy · Abstract.
Evaluating a Clinical Decision Support Tool for Antiretroviral ...
This study is testing software designed to help healthcare providers choose the best HIV treatment combinations for their patients.
8.
clinicalinfo.hiv.gov
clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdfGuidelines for the Use of Antiretroviral Agents in Adults and ...
Guidelines for the Use of Antiretroviral. Agents in Adults and Adolescents With HIV. Department of Health and Human Services. Available at https://clinicalinfo.
Guidelines for Using Antiretroviral Agents Among HIV ...
Preliminary data indicate that treatment of primary HIV infection with combination therapy has a beneficial effect on laboratory markers of disease ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.